Foolish Preview: Biogen Earnings

David Williamson, The Motley Fool
Updated

In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Biogen Idec's upcoming earnings report, and what the Big Biotech has in store for 2013.

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." Grab a free copy for a limited time. Just click here to access the report and find out the name of this under-the-radar company.


The article Foolish Preview: Biogen Earnings originally appeared on Fool.com.

David Williamson has no position in any stocks mentioned. Follow him on Twitter: @MotleyDavid. The Motley Fool recommends Quest Diagnostics. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement